CXCL12 and infarction: Direct intracardiac injection of SDF-1α protein in mice reduced infarct size, increased angiogenesis and improved cardiac function 4 weeks post-infarction,11,26–28 likely due to a combination of direct cardioprotection as well as stem cell recruitment.